Post

At last week’s #STATSummit, Dana Senaha told the story of her husband’s experience participating in the clinical trial for daraxonrasib. Watch: One family’s story of a life-extending medicine for pancreatic cancer https://bit.ly/4zVbNnP

statnews.comOne family’s story of a life-extending medicine for pancreatic cancerBobby Senaha was among the first patients to use daraxonrasib, a new life-extending drug for pancreatic cancer. His wife shares what those extra months meant to his family.

23/10/26, 8:47 pm2 reposts7 likes

curtisadams.bsky.social

@curtisadams.bsky.social

Stories like Bobby's are why this work matters. And the cancer evading the drug is why combinations are next. Pairing daraxonrasib with a drug hitting MTAP deleted tumors drove 82% responses, 100% disease control, and 88% free of progression at 9 months. His story is why they keep pushing.